Eagle Pharmaceuticals, inc. (EGRX)

[semi_infinite]

Traders are having a hard time deciding what the central value ought to be prior to patent decision. Premiums are staying about the same while the stock whipsaws. My guess is that it is somewhere in the range of 40-45 based upon the pricing of 30P and 60C.